Host gene expression is regulated by two types of noncoding RNAs transcribed from the Epstein-Barr virus BamHI a rightward transcript region

Journal of Virology

Volumn 89, Issue 22, 2015, Pages 11256-11268

  Marquitz, Aron R ^a   Mathur, Anuja ^a   Edwards, Rachel Hood ^a   Raab Traub, Nancy ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BAMHI A RIGHTWARD TRANSCRIPT RNA; COMPLEMENTARY DNA; LONG UNTRANSLATED RNA; MICRORNA; MYC PROTEIN; POLYADENYLATED RNA; UNCLASSIFIED DRUG; VIRUS RNA; X BOX BINDING PROTEIN 1; DNA BINDING PROTEIN; MESSENGER RNA; MYC PROTEIN, HUMAN; REGULATORY FACTOR X TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR; TYPE II SITE SPECIFIC DEOXYRIBONUCLEASE; XBP1 PROTEIN, HUMAN;

AGS CELL LINE; ALTERNATIVE RNA SPLICING; ARTICLE; BIOINFORMATICS; DOWN REGULATION; EPSTEIN BARR VIRUS; GASTRIC CANCER CELL LINE; GENE EXPRESSION REGULATION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; INTRON; LUCIFERASE ASSAY; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; RNA SEQUENCE; RNA TRANSCRIPTION; STOMACH CARCINOMA; TRANSCRIPTION REGULATION; VIRUS CARCINOGENESIS; VIRUS CELL INTERACTION; BIOSYNTHESIS; EPSTEIN BARR VIRUS INFECTION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; SEQUENCE ANALYSIS; STOMACH TUMOR; TUMOR CELL LINE; VIROLOGY;

BASE SEQUENCE; CELL LINE, TUMOR; DEOXYRIBONUCLEASE BAMHI; DNA-BINDING PROTEINS; DOWN-REGULATION; EPSTEIN-BARR VIRUS INFECTIONS; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS; MICRORNAS; PROTO-ONCOGENE PROTEINS C-MYC; REGULATORY FACTOR X TRANSCRIPTION FACTORS; RNA, LONG NONCODING; RNA, MESSENGER; RNA, VIRAL; SEQUENCE ANALYSIS, RNA; STOMACH NEOPLASMS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; X-BOX BINDING PROTEIN 1;

EID: 84945917596     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01492-15     Document Type: Article

References (44)

1. Longnecker RM, Cohen JI. 2013. Epstein-Barr virus, p 1898-1959. In Knipe DM, Howley PM (ed), Fields virology, 6th ed. Lippincott/Williams & Wilkins, Philadelphia, PA.
2. Raab-Traub N. 2002. Epstein-Barr virus in the pathogenesis of NPC. Semin Cancer Biol 12:431-441. http://dx.doi.org/10.1016/S1044579X0200086X.
3. Raab-Traub N, Flynn K. 1986. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 47:883-889. http://dx.doi.org/10.1016/0092-8674(86)90803-2.
4. Marquitz AR, Mathur A, Shair KH, Raab-Traub N. 2012. Infection of Epstein-Barr virus in a gastric carcinoma cell line induces anchorage independence and global changes in gene expression. Proc Natl Acad Sci U S A 109:9593-9598. http://dx.doi.org/10.1073/pnas.1202910109.
5. Raab-Traub N, Hood R, Yang CS, Henry B, II, Pagano JS. 1983. Epstein-Barr virus transcription in nasopharyngeal carcinoma. J Virol 48: 580-590.
6. Sadler RH, Raab-Traub N. 1995. Structural analyses of the Epstein-Barr virus BamHI A transcripts. J Virol 69:1132-1141.
7. Thornburg NJ, Kusano S, Raab-Traub N. 2004. Identification of Epstein-Barr virus RK-BARF0-interacting proteins and characterization of expression pattern. J Virol 78:12848-12856. http://dx.doi.org/10.1128/JVI.78.23.12848-12856.2004.
8. Al-Mozaini M, Bodelon G, Karstegl CE, Jin B, Al-Ahdal M, Farrell PJ. 2009. Epstein-Barr virus BART gene expression. J Gen Virol 90:307-316. http://dx.doi.org/10.1099/vir.0.006551-0.
9. Pfeffer S, Zavolan M, Grasser FA, Chien M, Russo JJ, Ju J, John B, Enright AJ, Marks D, Sander C, Tuschl T. 2004. Identification of virus-encoded microRNAs. Science 304:734-736. http://dx.doi.org/10.1126/science.1096781.
10. Cai X, Schafer A, Lu S, Bilello JP, Desrosiers RC, Edwards R, Raab-Traub N, Cullen BR. 2006. Epstein-Barr virus microRNAs are evolution-arily conserved and differentially expressed. PLoS Pathog 2:e23. http://dx.doi.org/10.1371/journal.ppat.0020023.
11. Zhu JY, Pfuhl T, Motsch N, Barth S, Nicholls J, Grasser F, Meister G. 2009. Identification of novel Epstein-Barr virus microRNA genes from nasopharyngeal carcinomas. J Virol 83:3333-3341. http://dx.doi.org/10.1128/JVI.01689-08.
12. Edwards RH, Marquitz AR, Raab-Traub N. 2008. Epstein-Barr virus BART microRNAs are produced from a large intron prior to splicing. J Virol 82:9094-9106. http://dx.doi.org/10.1128/JVI.00785-08.
13. Strong MJ, Xu G, Coco J, Baribault C, Vinay DS, Lacey MR, Strong AL, Lehman TA, Seddon MB, Lin Z, Concha M, Baddoo M, Ferris M, Swan KF, Sullivan DE, Burow ME, Taylor CM, Flemington EK. 2013. Differences in gastric carcinoma microenvironment stratify according to EBV infection intensity: implications for possible immune adjuvant therapy. PLoS Pathog 9:e1003341. http://dx.doi.org/10.1371/journal.ppat.1003341.
14. Cancer Genome Atlas Research Network. 2014. Comprehensive molecular characterization of gastric adenocarcinoma. Nature 513:202-209. http://dx.doi.org/10.1038/nature13480.
15. Marquitz AR, Mathur A, Chugh PE, Dittmer DP, Raab-Traub N. 2014. Expression profile of microRNAs in Epstein-Barr virus-infected AGS gastric carcinoma cells. J Virol 88:1389-1393. http://dx.doi.org/10.1128/JVI.02662-13.
16. Kassis J, Maeda A, Teramoto N, Takada K, Wu C, Klein G, Wells A. 2002. EBV-expressing AGS gastric carcinoma cell sublines present increased motility and invasiveness. Int J Cancer 99:644-651. http://dx.doi.org/10.1002/ijc.10382.
17. Mercer TR, Mattick JS. 2013. Structure and function of long noncoding RNAs in epigenetic regulation. Nat Structural Mol Biol 20:300-307. http://dx.doi.org/10.1038/nsmb.2480.
18. Batista PJ, Chang HY. 2013. Long noncoding RNAs: cellular address codes in development and disease. Cell 152:1298-1307. http://dx.doi.org/10.1016/j.cell.2013.02.012.
19. Wille CK, Nawandar DM, Panfil AR, Ko MM, Hagemeier SR, Kenney SC. 2013. Viral genome methylation differentially affects the ability of BZLF1 versus BRLF1 to activate Epstein-Barr virus lytic gene expression and viral replication. J Virol 87:935-950. http://dx.doi.org/10.1128/JVI.01790-12.
20. Hermeking H, Rago C, Schuhmacher M, Li Q, Barrett JF, Obaya AJ, O'Connell BC, Mateyak MK, Tam W, Kohlhuber F, Dang CV, Sedivy JM, Eick D, Vogelstein B, Kinzler KW. 2000. Identification of CDK4 as a target of c-MYC. Proc Natl Acad Sci U S A 97:2229-2234. http://dx.doi.org/10.1073/pnas.050586197.
21. Robinson JT, Thorvaldsdottir H, Winckler W, Guttman M, Lander ES, Getz G, Mesirov JP. 2011. Integrative genomics viewer. Nat Biotechnol 29:24-26. http://dx.doi.org/10.1038/nbt.1754.
22. Mainou BA, Everly DN, Jr, Raab-Traub N. 2005. Epstein-Barr virus latent membrane protein 1 CTAR1 mediates rodent and human fibroblast transformation through activation of PI3K. Oncogene 24:6917-6924. http://dx.doi.org/10.1038/sj.onc.1208846.
23. Concha M, Wang X, Cao S, Baddoo M, Fewell C, Lin Z, Hulme W, Hedges D, McBride J, Flemington EK. 2012. Identification of new viral genes and transcript isoforms during Epstein-Barr virus reactivation using RNA-Seq. J Virol 86:1458-1467. http://dx.doi.org/10.1128/JVI.06537-11.
24. Hetz C, Chevet E, Harding HP. 2013. Targeting the unfolded protein response in disease. Nat Rev Drug Discov 12:703-719. http://dx.doi.org/10.1038/nrd3976.
25. Gottwein E, Corcoran DL, Mukherjee N, Skalsky RL, Hafner M, Nusbaum JD, Shamulailatpam P, Love CL, Dave SS, Tuschl T, Ohler U, Cullen BR. 2011. Viral microRNA targetome of KSHV-infected primary effusion lymphoma cell lines. Cell Host Microbe 10:515-526. http://dx.doi.org/10.1016/j.chom.2011.09.012.
26. Kang D, Skalsky RL, Cullen BR. 2015. EBV BART MicroRNAs target multiple proapoptotic cellular genes to promote epithelial cell survival. PLoS Pathog 11:e1004979. http://dx.doi.org/10.1371/journal.ppat.1004979.
27. Marquitz AR, Raab-Traub N. 2012. The role of miRNAs and EBV BARTs in NPC. Semin Cancer Biol 22:166-172. http://dx.doi.org/10.1016/j.semcancer.2011.12.001.
28. Cao S, Strong MJ, Wang X, Moss WN, Concha M, Lin Z, O'Grady T, Baddoo M, Fewell C, Renne R, Flemington EK. 2015. High-throughput RNA sequencing-based virome analysis of 50 lymphoma cell lines from the Cancer Cell Line Encyclopedia project. J Virol 89:713-729. http://dx.doi.org/10.1128/JVI.02570-14.
29. Szeto CY, Lin CH, Choi SC, Yip TT, Ngan RK, Tsao GS, Li Lung M. 2014. Integrated mRNA and microRNA transcriptome sequencing characterizes sequence variants and mRNA-microRNA regulatory network in nasopharyngeal carcinoma model systems. FEBS Open Bio 4:128-140. http://dx.doi.org/10.1016/j.fob.2014.01.004.
30. Rowe M, Kelly GL, Bell AI, Rickinson AB. 2009. Burkitt's lymphoma: the Rosetta Stone deciphering Epstein-Barr virus biology. Semin Cancer Biol 19:377-388. http://dx.doi.org/10.1016/j.semcancer.2009.07.004.
31. Kaiser C, Laux G, Eick D, Jochner N, Bornkamm GW, Kempkes B. 1999. The proto-oncogene c-myc is a direct target gene of Epstein-Barr virus nuclear antigen 2. J Virol 73:4481-4484.
32. Qiu J, Cosmopoulos K, Pegtel M, Hopmans E, Murray P, Middeldorp J, Shapiro M, Thorley-Lawson DA. 2011. A novel persistence associated EBV miRNA expression profile is disrupted in neoplasia. PLoS Pathog 7:e1002193. http://dx.doi.org/10.1371/journal.ppat.1002193.
33. Akao Y, Nakagawa Y, Naoe T. 2006. let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. Biol Pharm Bull 29:903-906. http://dx.doi.org/10.1248/bpb.29.903.
34. Sampson VB, Rong NH, Han J, Yang Q, Aris V, Soteropoulos P, Petrelli NJ, Dunn SP, Krueger LJ. 2007. MicroRNA let-7a downregulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. Cancer Res 67:9762-9770. http://dx.doi.org/10.1158/0008-5472.CAN-07-2462.
35. Kim do, N, Chae HS, Oh ST, Kang JH, Park CH, Park WS, Takada K, Lee JM, Lee WK, Lee SK. 2007. Expression of viral microRNAs in Epstein-Barr virus-associated gastric carcinoma. J Virol 81:1033-1036. http://dx.doi.org/10.1128/JVI.02271-06.
36. Raab-Traub N, Dambaugh T, KieffE. 1980. DNA of Epstein-Barr virus VIII: B95-8, the previous prototype, is an unusual deletion derivative. Cell 22:257-267. http://dx.doi.org/10.1016/0092-8674(80)90173-7.
37. Seto E, Moosmann A, Gromminger S, Walz N, GrundhoffA, Hammerschmidt W. 2010. Micro RNAs of Epstein-Barr virus promote cell cycle progression and prevent apoptosis of primary human B cells. PLoS Pathog 6:e1001063. http://dx.doi.org/10.1371/journal.ppat.1001063.
38. Qiu J, Smith P, Leahy L, Thorley-Lawson DA. 2015. The Epstein-Barr virus encoded BART miRNAs potentiate tumor growth in vivo. PLoS Pathog 11:e1004561. http://dx.doi.org/10.1371/journal.ppat.1004561.
39. Reimold AM, Iwakoshi NN, Manis J, Vallabhajosyula P, Szomolanyi-Tsuda E, Gravallese EM, Friend D, Grusby MJ, Alt F, Glimcher LH. 2001. Plasma cell differentiation requires the transcription factor XBP-1. Nature 412:300-307. http://dx.doi.org/10.1038/35085509.
40. Bhende PM, Dickerson SJ, Sun X, Feng WH, Kenney SC. 2007. X-boxbinding protein 1 activates lytic Epstein-Barr virus gene expression in combination with protein kinase D. J Virol 81:7363-7370. http://dx.doi.org/10.1128/JVI.00154-07.
41. Zhou D, Palam LR, Jiang L, Narasimhan J, Staschke KA, Wek RC. 2008. Phosphorylation of eIF2 directs ATF5 translational control in response to diverse stress conditions. J Biol Chem 283:7064-7073. http://dx.doi.org/10.1074/jbc. M708530200.
42. Margueron R, Reinberg D. 2011. The Polycomb complex PRC2 and its mark in life. Nature 469:343-349. http://dx.doi.org/10.1038/nature09784.
43. Kang GH, Lee S, Kim WH, Lee HW, Kim JC, Rhyu MG, Ro JY. 2002. Epstein-barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma. Am J Pathol 160:787-794. http://dx.doi.org/10.1016/S0002-9440(10)64901-2.
44. Vo QN, Geradts J, Gulley ML, Boudreau DA, Bravo JC, Schneider BG. 2002. Epstein-Barr virus in gastric adenocarcinomas: association with ethnicity and CDKN2A promoter methylation. J Clin Pathol 55:669-675. http://dx.doi.org/10.1136/jcp.55.9.669.